Ancora Advisors’s Bionano Genomics BNGO Stock Holding History

Ancora Advisors’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1	Hold	1	–	–	﹤0.01%	2386
2025 Q4	$2	Hold	1	–	–	﹤0.01%	2421
2025 Q3	$2	Hold	1	–	–	﹤0.01%	1961
2025 Q2	$3	Buy	+1	New	+$4	﹤0.01%	1955
2023 Q2	–	Sell	-2	Closed	-$1.11K	–	1810
2023 Q1	$1.11K	Hold	2	–	–	﹤0.01%	1613
2022 Q4	$1K	Hold	2	–	–	﹤0.01%	1659
2022 Q3	$2K	Hold	2	–	–	﹤0.01%	1774
2022 Q2	$1K	Hold	2	–	–	﹤0.01%	2060
2022 Q1	$3K	Hold	2	–	–	﹤0.01%	2064
2021 Q4	$3K	Hold	2	–	–	﹤0.01%	2130
2021 Q3	$5K	Hold	2	–	–	﹤0.01%	1891
2021 Q2	$7K	Hold	2	–	–	﹤0.01%	1609
2021 Q1	$8K	Buy	+2	New	+$11.3K	﹤0.01%	1479

Other funds holding BNGO

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAM

Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Ancora Advisors's BNGO Position: Q1 2026 in Review

Ancora Advisors held its Bionano Genomics (BNGO) position steady in Q1 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #2386.

Ancora Advisors first reported a position in BNGO in Q1 2021 and has held it in 13 quarters since. The position peaked at $8K in Q1 2021. 32 funds tracked by Wall St. Rank hold BNGO as of Q1 2026.

Ancora Advisors held 1 share of Bionano Genomics worth $1 as of Q1 2026.
Ancora Advisors left its Bionano Genomics share count unchanged in Q1 2026.
Bionano Genomics made up ﹤0.01% of Ancora Advisors's portfolio in Q1 2026, its #2386 holding.
Ancora Advisors first reported a position in Bionano Genomics in Q1 2021 and has held it in 13 quarters since.
Ancora Advisors's Bionano Genomics position peaked at $8K in Q1 2021.
32 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.